June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountvitalmore.co.jp
Global Rank
- -
Country Rank
- -
Category Rank
- -
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
47.06%
Pages per Visit
1.32
Avg Visit Duration
00:00:16
- Company
- - -
- Industry
- - -
Top 10 vitalmore.co.jp Competitors
The Top 10 Sites Like vitalmore.co.jp in June 2026 are ranked by their affinity to vitalmore.co.jp in terms of keyword traffic, audience targeting, and market overlap
「癌・機能性成分の比較情報ガイド」では、がんに対する機能性成分の信頼性や効果に関する最新情報を、客観的な評価ができるように、良い情報だけでなく副作用などの情報も臨床試験や論文で報告のあるものは記載しています。がんに対する機能性成分について知る情報としてご活用ください。
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
100%
Pages per Visit
1.00
Avg Visit Duration
- -
Similarity Score
99%健康食品通販サイト。
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
46.83%
Pages per Visit
1.68
Avg Visit Duration
00:00:31
Similarity Score
61%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
38%vitalmore.co.jp's top 5 competitors in June 2026 are: men-eki.net, kimura-fucoidan1.jp, kenbicare.com, toyo-project.jp, and more.
According to Similarweb data of monthly visits, vitalmore.co.jp’s top competitor in June 2026 is men-eki.net. vitalmore.co.jp 2nd most similar site is kimura-fucoidan1.jp, and closing off the top 3 is kenbicare.com.
toyo-project.jp ranks as the 4th most similar website to vitalmore.co.jp and ranks fifth in June 2026.
The other five competitors in the top 10 list are , , , , and .